1. Home
  2. ORGO vs EQV Comparison

ORGO vs EQV Comparison

Compare ORGO & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGO
  • EQV
  • Stock Information
  • Founded
  • ORGO 1985
  • EQV 2024
  • Country
  • ORGO United States
  • EQV United States
  • Employees
  • ORGO N/A
  • EQV N/A
  • Industry
  • ORGO Biotechnology: Pharmaceutical Preparations
  • EQV
  • Sector
  • ORGO Health Care
  • EQV
  • Exchange
  • ORGO Nasdaq
  • EQV Nasdaq
  • Market Cap
  • ORGO 539.1M
  • EQV 463.6M
  • IPO Year
  • ORGO N/A
  • EQV 2024
  • Fundamental
  • Price
  • ORGO $3.97
  • EQV $10.46
  • Analyst Decision
  • ORGO Buy
  • EQV
  • Analyst Count
  • ORGO 3
  • EQV 0
  • Target Price
  • ORGO $7.33
  • EQV N/A
  • AVG Volume (30 Days)
  • ORGO 717.2K
  • EQV 56.1K
  • Earning Date
  • ORGO 11-06-2025
  • EQV 01-01-0001
  • Dividend Yield
  • ORGO N/A
  • EQV N/A
  • EPS Growth
  • ORGO N/A
  • EQV N/A
  • EPS
  • ORGO N/A
  • EQV N/A
  • Revenue
  • ORGO $429,531,000.00
  • EQV N/A
  • Revenue This Year
  • ORGO $2.51
  • EQV N/A
  • Revenue Next Year
  • ORGO $25.45
  • EQV N/A
  • P/E Ratio
  • ORGO N/A
  • EQV $50.97
  • Revenue Growth
  • ORGO N/A
  • EQV N/A
  • 52 Week Low
  • ORGO $2.61
  • EQV $9.91
  • 52 Week High
  • ORGO $6.71
  • EQV $10.74
  • Technical
  • Relative Strength Index (RSI)
  • ORGO 40.52
  • EQV 67.17
  • Support Level
  • ORGO $3.84
  • EQV $10.42
  • Resistance Level
  • ORGO $4.30
  • EQV $10.43
  • Average True Range (ATR)
  • ORGO 0.18
  • EQV 0.03
  • MACD
  • ORGO 0.00
  • EQV 0.00
  • Stochastic Oscillator
  • ORGO 23.64
  • EQV 68.75

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About EQV EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp is a blank check company.

Share on Social Networks: